CSI Market
Sign In | Register

Palisade Bio Inc (PALI) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access PALI quarterly Cash Flow →
By examining cash flow figures across successive periods, users can identify shifts in Palisade Bio Inc's cash generation and deployment strategy.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-16.78
Depreciation & amortization0.00
Amortization of Other Assets0.00
Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
Research and Development in Process0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property0.00
Share-based Compensation3.96
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Other Nonoperating Expense-
Derivative Gain Loss On Derivative Net-
Increase Decrease In R O U And Other Assets-
Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities Noncash Transaction Costs Shared With Acquiree-
Noncash Lease Expense-
Accounts Payable Written Off-
Vesting Expense Restricted Stock Units-
Noncash Operating Lease Expense0.08
Increase Decrease In Operating Lease Liability-0.09
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Employee Related Liabilities0.58
Increase (Decrease) in Accounts Payable and Accrued Liabilities0.62
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.53
Other Working Capital-0.06
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.31
Discontinued operations0.00
Net Cash flow from Operating Activities-10.85
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net-0.32
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock135.26
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-9.85
Proceeds From Issuance Of Public And Private Placement-
Payment Of Employee Taxes On Stock Option Exercise-
Proceeds From Exercise Of Stock Purchase Warrants Net Of Issuance Costs-
Proceeds From Issuance Or Sale Of Equity Net Of Issuance Costs-
Payments Of Fees Related To Prior Financing-
Proceeds From Issuance Of Common Stock Net-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations9.85
Payment Of Warrant Inducement Issuance Costs-0.50
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities134.44
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-10.85
Total Cash Flow123.59
4 historic quarters locked

Sign in to unlock the full Palisade Bio Inc cash flow history.

Sign In Create Free Account

About Palisade Bio Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001357459-26-000004

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License